AWA
GILD icon

ARS Wealth Advisors’s Gilead Sciences GILD Stock Holding History

ARS Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15,691
Closed -$1.12M – 117
2016
Q4 		$1.12M Sell
15,691
-2,282
-13% -$170K 0.5% 28
2016
Q3 		$1.42M Buy
17,973
+680
+4% +$55.2K 0.6% 24
2016
Q2 		$1.44M Sell
17,293
-716
-4% -$63.5K 0.61% 23
2016
Q1 		$1.65M Buy
18,009
+1,294
+8% +$117K 0.78% 20
2015
Q4 		$1.69M Buy
+16,715
New +$1.74M 0.87% 17

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

ARS Wealth Advisors's GILD Position: Q1 2017 in Review

ARS Wealth Advisors sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 15,691 shares — an estimated $1.12M sold.

ARS Wealth Advisors first reported a position in GILD in Q4 2015 and held it in 5 quarters. The position peaked at $1.69M in Q4 2015. 1,526 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • ARS Wealth Advisors reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • ARS Wealth Advisors sold 15,691 Gilead Sciences shares in Q1 2017, an estimated $1.12M.
  • ARS Wealth Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 5 quarters.
  • ARS Wealth Advisors's Gilead Sciences position peaked at $1.69M in Q4 2015.
  • 1,526 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on ARS Wealth Advisors's 13F filing for Q1 2017, filed 11 Jun 2021.